I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … period 2000–2009, by estimating difference-in-differences models using longitudinal (annual) data on ∼60 cancer sites (breast …-adjusted cancer mortality rate during 2000–2009. Drug innovation and imaging innovation are estimated to have reduced the cancer …

We present three types of evidence about the effect of cancer drug vintage-year of initial world launch - on cancer …-series models. The first analysis uses data on cancer drug vintage, survival, and other variables, by primary cancer site and year …, for U.S. cancer patients during the period 1992-2002. We control for cancer stage distribution, mean age at diagnosis …

Innovations in cancer treatment have lowered mortality, but little is known about their economic benefits. We assess … the effect of two decades of improvements in cancer treatment options on the labor market outcomes of breast and prostate … cancer patients. In addition, we compare this effect across cancer patients with different levels of educational attainment …

Innovations in cancer treatment have lowered mortality, but little is known about their economic benefits. We assess … the effect of two decades of improvement in cancer treatment options on the labor market outcomes of breast and prostate … cancer patients. In addition, we compare this effect across cancer patients with different levels of educational attainment …

Lung cancer is one of main cause of death worldwide and traditional chemotherapy agents have reached the maturity phase … in the treatment of advanced non-small cell lung cancer. The purpose of this paper is to analyse the evolutionary growth … of knowledge patterns of vital radical innovations to treat lung cancer, driven by new technological paradigm of the …

Lung cancer is the second most common type of cancer and it has the highest mortality rate worldwide. The purpose of … this paper is to analyse the evolutionary growth of knowledge of radical innovations to treat lung cancer which are … agents seem to have reached the maturity phase in the treatment of advanced nonsmall cell lung cancer because of the …